The virus, technically known as Langya henipavirus (LayV), is completely new and has never before affected people.

It indeed belong to the Henipavirus family, of which the Hendra and Nipah viruses are two species that have been previously identified.

According to data from the World Health Organization, the case fatality rate for henipavirus is between 40% and 75%, making it a biosafety level 4 virus (WHO).

Chinese researchers said that the patients were evaluated because they were febrile in a publication that appeared in the New England Journal of Medicine (NEJM).

According to the Global Times, none of the 35 individuals who have the novel Langya virus infection have died or experienced any major side effects.

Their most frequent symptoms included fever, exhaustion, a cough, appetite loss, muscle discomfort, nausea, headaches, and vomiting.

According to the study, there was no history of frequent close contact or exposure among the patients, which indicates that the infection may be sporadic in the general population.

It brings back memories of the Covid epidemic, when China only reported a small number of novel coronavirus cases that were solely assumed to be caused by animal transmission.

More of these viruses, such as Covid, Zika, and Ebola, are emerging due to a number of circumstances.

These include the extinction of species, the trade in and consumption of animals, and climate change. The Nipah virus was initially identified in 1999.